by Jordana Choucair | Aug 26, 2021 | M&A
Headspace and Ginger announced plans to merge in a deal that values the combined company at $3 billion. The new company, called Headspace Health, boasts more than 2,700 enterprise and health plan customers with combined bookings of nearly $300 million by end of 2021....
by Jordana Choucair | Aug 26, 2021 | Life Sciences
Pfizer and Moderna announced plans to seek additional FDA approvals for their respective COVID-19 vaccines. Pfizer said it will submit its application for a third dose of its vaccine for everyone ages 16 and older by the end of this week. Federal regulators are likely...
by Jordana Choucair | Aug 26, 2021 | Access & Coverage
Congressional Democrats are looking to create a new federal program to provide health insurance coverage in the 12 Republican-led states that have declined to expand Medicaid. The program would be part of the $3.5 trillion budget resolution. Initially, the federal...
by webmaster | Aug 25, 2021 | Public Health/Prevention
The U.S. Preventive Services Task Force published new guidance recommending that overweight and obese Americans should start getting screened for diabetes at age 35 instead of 40. The new guidelines stem from rising rates of both obesity and Type 2 diabetes, and...
by webmaster | Aug 25, 2021 | Providers
Kaufman Hall’s latest National Hospital Flash Report found that hospital margins and volumes remain below pre-pandemic numbers. Hospitals in the South and Midwest saw the biggest year-over-year drops in margins driven by high rates of the delta variant and...
by webmaster | Aug 25, 2021 | Life Sciences
Johnson & Johnson said a second dose of its COVID-19 vaccine generated a strong immune response in a study, with antibody levels ninefold higher among those who got a second shot compared with one month after their first dose. The company said the data makes the...
Recent Comments